Loading
Milestone Pharmaceuticals Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Bharucha David, was filed 05 Dec 2022.
Milestone Pharmaceuticals Inc.: what insiders have been doing
This page follows insider dealings at Milestone Pharmaceuticals Inc. as filed with SEC (Form 4), a company from the Health Care sector. In the past year (25 October 2025 to 25 October 2026), 31 filings came from 6 insiders.
No insider bought on the market over the period, while 5 insiders filed 20 sales totalling €977k. One trade stands out by size: a sale of €263k from Oliveto Joseph, disclosed on 28 January 2026.
For context, the typical company on the same exchange (median of 3,167 companies) published 24 filings over the same period, against 31 filings here. The full history, which starts in 2019, counts 63 purchases against 25 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists net income at -63.1 m USD.
The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
161
Thresholds
n/a
Buy Volume
€60M
63 ops. · all time
Sell Volume
€12M
25 ops. · all time
Who traded when
BuySaleJoseph Gerard Oliveto9 sales
Joseph Oliveto5 sales
Amit Hasija2 sales
David Bharucha2 sales
Lorenz Muller2 sales
Since the insiders bought
- -29.0%Entry US$4.51 · Close at T+365 US$3.20
- -48.7%Entry US$5.07 · Close at T+365 US$2.60
- -48.7%Entry US$5.07 · Close at T+365 US$2.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Milestone Pharmaceuticals Inc. Strong Buy (bullish), based on 7 analysts. Average price target: US$5.86.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.70
Analyst consensus
7 analystsStrong buy
US$2.00Target US$5.86(+732%)US$8.00
Income statement
RevenueUS$1.5M
EBITDA-US$59.1M-3823% margin
Net income-US$63.1M-4078.8% margin
Valuation
PER (forward)-0.9x
P/Book5.5x
Beta1.01
Balance sheet & cash
Market capUS$87.6M
Total debtUS$58.4M
Free Cash Flow-US$49.3M
Debt / Equity779%
Profitability & ownership
ROE-35522.6%
ROA-42.8%
% insiders0.7%
% institutions51.5%
Last declaration on 20 April 2026
Declarations161 total
1,400 shares@ CA$2.281.1% of flowCommon SharesTSXSEDI:4707203
4,600 shares@ CA$2.273.7% of flowCommon SharesTSXSEDI:4707202
16,584 shares@ CA$2.2613.4% of flowCommon SharesTSXSEDI:4707201
2,360 shares@ CA$2.2551.9% of flowCommon SharesTSXSEDI:4707199
11,556 shares@ CA$2.259.3% of flowCommon SharesTSXSEDI:4707198
36,500 shares@ US$2.260.053% mcap98.6% of flowCommon SharesSEC:0001437782-26-000010:0
58,007 shares@ US$2.3285.2% of flowCommon SharesSEC:0001943112-26-000002:1
12,245 shares@ US$1.9314.8% of flowCommon SharesSEC:0001943112-26-000002:3
20,100 sharesCommon SharesSEC:0001910985-26-000003:2
20,100 sharesCommon SharesSEC:0001771207-26-000002:2
20,100 sharesCommon SharesSEC:0001787700-26-000002:2
20,100 sharesCommon SharesSEC:0001943112-26-000002:2
66,600 sharesCommon SharesSEC:0001437782-26-000004:2
58,007 shares@ US$2.3263.8% of flowCommon SharesSEC:0001910985-26-000003:1
12,245 shares@ US$1.9311.1% of flowCommon SharesSEC:0001910985-26-000003:3
53,566 shares@ US$2.3251.2% of flowCommon SharesSEC:0001771207-26-000002:1
11,180 shares@ US$1.938.8% of flowCommon SharesSEC:0001771207-26-000002:3
58,007 shares@ US$2.3285.2% of flowCommon SharesSEC:0001787700-26-000002:1
12,245 shares@ US$1.9314.8% of flowCommon SharesSEC:0001787700-26-000002:3
133,054 shares@ US$2.3254.4% of flowCommon SharesSEC:0001437782-26-000004:1
34,523 shares@ US$1.9311.6% of flowCommon SharesSEC:0001437782-26-000004:3
100,000 sharesCommon SharesSEC:0001943112-26-000002:0
100,000 sharesCommon SharesSEC:0001910985-26-000003:0
100,000 sharesCommon SharesSEC:0001787700-26-000002:0
100,000 sharesCommon SharesSEC:0001771207-26-000002:0
25 of 161 declarations
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative treatments for cardiovascular diseases. It is listed on NASDAQ under the ticker MIST.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
